Last updated: 11/07/2018 14:01:06
Paroxetine in Depressed Patients with Ischemic Heart Disease- A Randomized Safety Study
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Paroxetine in Depressed Patients with Ischemic Heart Disease- A Randomized Safety Study
Trial description: Paroxetine in Depressed Patients with Ischemic Heart Disease- A Randomized Safety Study
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Nortriptyline versa paroxetine in depressed ischemic heart disease patients: a multicenter randomized double-blind clinical trial. Laghrissi-Thode, F MD, Kennedy, J MD, Nelson, J C MD, Pollock, B MD, Gaffney, A MD, Finkel, M MD, Gergel, I MD, McCafferty, J MD, Sackeim, H MD, and Roose, S MD American College of Neuropsychopharmacology 34th Annual Meeting 12/11/1995 San Juan; Puerto Rico
Nortriptyline versa paroxetine: a multicenter randomized prospective double-blind, clinical trial in depressed ischemic heart disease patients. Kennedy, J S MD, Robin, D MD, Pollock, B MD, Nelson, J D MD, Sackeim, H MD, Laghrissi-Thode, F MD, Finkle, M MD, Gorgel, L MD, McCafferty, J MD, and Roose, S MD American Association for Geriatric Psychiatry 9th Annual Meeting and Symposium 2/14/1996 Tucson, AZ; USA
Nortryptyline versa paroxetine in depressed ischemic heart disease patients: a multicenter randomised double blind clinical trial. Judge, R, Laghrissi-Thode, F, Kennedy, J, Nelson, J C, Pollack, B, Gaffney, A, Finkel, M, Roose, H S, Gergel, I, and McCafferty, J International Academy for Biomedical and Drug Research 1996 Campaign on Interface Between Psychiatry and Internal Medicine Workshop on New Therapeutic Indications of Antidepressants 3/22/1996 Brugge; Belgium
Paroxetine in the treatment of depressed patients with ischaemic heart disease. Roose, S, Pollock, B, Kennedy, J, Nelson, J, Gergel, I, McCafferty, J, Bushnell, W, and Kumar, R 6th World Congress of Biological Psychiatry 6/22/1997 Nice; France
Paroxetine versus nortriptyline in ischemic disease. Roose, S P MD, Pollack, B MD, Kennedy, J MD, Nelson, C MD, McCafferty, J MD, and Gergel, I MD American Psychiatric Association Annual Meeting 5/17/1997 San Diego, CA; USA
Randomized trial of antidepressants in patients with ischemic heart disease. Mitchell S. Finkel, Andrew Gaffney Fouzia Laghrissi-Thode Bruce G. Pollock John Kennedy Craig Nelson Ivan Gergel James P. McCafferty Steven P. Roose American College of Cardiology 45th Annual Scientific Sessions 3/24/1996 Orlando, FL; USA
Roose SP et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998; 279:287-291.
Medical condition
Depressive Disorder, Major
Product
paroxetine
Collaborators
Not applicable
Study date(s)
February 1994 to April 1995
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1995-28-04
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website